Why the study?
Do genetic variants in PNPLA3 contribute to differences in hepatic fat content and susceptibility to NAFLD?
Observational
Do genetic variants in PNPLA3 contribute to differences in hepatic fat content and susceptibility to NAFLD?
p-value: p=5.9 × 10(-10)
Genetic variation in PNPLA3 is strongly associated with hepatic fat content and inflammation, explaining ancestry-related differences in NAFLD susceptibility.
PNPLA3 variant may underlie ancestry differences in NAFLD risk; leaves open validation for risk stratification or targeted therapies.
Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem of unknown etiology that varies in prevalence among ancestry groups. To identify genetic variants contributing to differences in hepatic fat content, we carried out a genome-wide association scan of nonsynonymous sequence variations (n = 9,229) in a population comprising Hispanic, African American and European American individuals. An allele in PNPLA3 (rs738409[G], encoding I148M) was strongly associated with increased hepatic fat levels (P = 5.9 × 10(-10)) and with hepatic inflammation (P = 3.7 × 10(-4)). The allele was most common in Hispanics, the group most susceptible to NAFLD; hepatic fat content was more than twofold higher in PNPLA3 rs738409[G] homozygotes than in noncarriers. Resequencing revealed another allele of PNPLA3 (rs6006460[T], encoding S453I) that was associated with lower hepatic fat content in African Americans, the group at lowest risk of NAFLD. Thus, variation in PNPLA3 contributes to ancestry-related and inter-individual differences in hepatic fat content and susceptibility to NAFLD.
No takes yet. Share an insight, caveat, or question.
Weiskirchen et al. (2009) conducted an observational in Nonalcoholic fatty liver disease (NAFLD). PNPLA3 rs738409[G] allele vs. Noncarriers was evaluated on Hepatic fat levels (p=5.9 × 10(-10)).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: